Cargando…

Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis

BACKGROUND: Percutaneous coronary intervention (PCI) is an important means for the treatment of coronary atherosclerotic heart disease and has effectively reduced the mortality of coronary heart disease. However, reperfusion can also cause certain damage to the vascular endothelium, leading to the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Lina, Yuan, Xianying, Jiang, Lihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878783/ https://www.ncbi.nlm.nih.gov/pubmed/35212312 http://dx.doi.org/10.1097/MD.0000000000028994

Ejemplares similares

The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
por: Du, Jinling, et al.
Publicado: (2016)

The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
por: Li, Cailan, et al.
Publicado: (2020)

Effect of Shexiang Tongxin dropping pill on stable coronary artery disease patients with normal fractional flow reserve and coronary microvascular disease: A study protocol
por: Lu, Yanli, et al.
Publicado: (2020)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

The effect of Shexiang Tongxin Dropping Pills on coronary microvascular dysfunction (CMVD) among those with a mental disorder and non-obstructive coronary artery disease based on stress cardiac magnetic resonance images: A study protocol
por: Tian, Jinfan, et al.
Publicado: (2020)

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study
por: Hu, Yue-cheng, et al.
Publicado: (2021)

Effects of Shenxiang Suhe Pill on coronary heart disease complicated with nonalcoholic fatty liver disease: A case–control study
por: Ni, Jie, et al.
Publicado: (2022)

Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Liu, Shengxiang, et al.
Publicado: (2021)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020)

Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome
por: Wei, Mei, et al.
Publicado: (2019)

Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Dai, Haiyue, et al.
Publicado: (2021)

Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis
por: Sun, Ling, et al.
Publicado: (2022)

Intravascular ultrasound-guided percutaneous coronary intervention for patients with coronary bifurcation lesions: A systematic review and meta-analysis
por: Yang, Rong-Rong, et al.
Publicado: (2020)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
por: Chen, Xixi, et al.
Publicado: (2023)

Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk
por: Zhao, Yunfeng, et al.
Publicado: (2021)

Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Liu, Xiao-Qiang, et al.
Publicado: (2020)

Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome
por: Li, Miaonan, et al.
Publicado: (2017)

Comparison of coronary artery bypass grafting and percutaneous coronary intervention for syphilitic coronary artery ostial lesions: A 4-year retrospective study
por: Han, Junyu, et al.
Publicado: (2020)

Clinical evaluation of high intensity interval training exercise in coronary heart disease patients after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Cheng, Xiaohui, et al.
Publicado: (2021)

Relationship between long non-coding RNA and prognosis of patients with coronary heart disease after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Wang, Fei, et al.
Publicado: (2020)

Systematic Review of Compound Danshen Dropping Pill: A Chinese Patent Medicine for Acute Myocardial Infarction
por: Luo, Jing, et al.
Publicado: (2013)

Elucidating direct kinase targets of compound Danshen dropping pills employing archived data and prediction models
por: Wang, Tongxing, et al.
Publicado: (2021)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

Treatment of coronary pseudoaneurysm detected after percutaneous coronary intervention for chronic total occlusion: A case report
por: Li, Xudong, et al.
Publicado: (2023)

Objectifying the level of incomplete revascularization by residual SYNTAX score and evaluating the impact of incomplete revascularization on exercise tolerance in patients with coronary atherosclerotic heart disease treated by percutaneous coronary intervention
por: Xue, Lin, et al.
Publicado: (2020)

Predictive performance of aortic arch calcification for clinical outcomes in patients with acute coronary syndrome that undergo percutaneous coronary intervention: A prospective clinical study
por: Ma, Xiaoteng, et al.
Publicado: (2019)

Hematological Parameters Improve Prediction of Mortality and Secondary Adverse Events in Coronary Angiography Patients: A Longitudinal Cohort Study
por: Gijsberts, Crystel M., et al.
Publicado: (2015)

A single-center observational study on the efficacy of percutaneous coronary intervention for ischemic heart failure: A cohort study
por: Wang, Zongtao, et al.
Publicado: (2018)

Prognostic Significance of Central Pulse Pressure for Mortality in Patients With Coronary Artery Disease Receiving Repeated Percutaneous Coronary Intervention
por: Lin, Mao-Jen, et al.
Publicado: (2016)

Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2019)

Prognostic value of CHADS(2) and CHA(2)DS(2)-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Ma, Xiaoteng, et al.
Publicado: (2020)

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials
por: Liu, Jiahui, et al.
Publicado: (2021)

Magnetic navigation system for percutaneous coronary intervention: A meta-analysis
por: Qi, Zhiyong, et al.
Publicado: (2016)

Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Percutaneous coronary intervention versus cardiac bypass surgery for left main coronary artery disease: A trial sequential analysis
por: Ye, Yicong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aij8flsvhbto7pc93l4opqmap6